SHL.DE
Siemens Healthineers AG
XETRAEUREQUITY
Healthcare
DELAYED
Last price
40.20
▲ 0.39 (0.98%)
MARKET · —
Price
Open
39.64
Prev close
39.81
Day high
40.23
Day low
39.44
Volume
533.29K
Market cap
$44.99B
P/E (TTM)
20.62
52W range
32.81 – 49.71
Trailing performance
Returnvs SPY
1W
+2.26%
+3.6%
1M
+18.13%
+14.4%
3M
+16.12%
+13.0%
6M
-3.25%
-14.3%
YTD
-10.51%
-22.8%
1Y
-16.22%
-36.2%
3Y
-12.87%
-87.0%
5Y
-29.82%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$44.99B
Enterprise value$57.53B
Revenue (TTM)$23.17B
Gross profit$9.04B
EBITDA$4.02B
Net income$2.21B
EPS (TTM)$1.95
Free cash flow$2.15B
Total cash$2.36B
Total debt$15.00B
Book value / share$17.13
Shares outstanding1.12B
Float357.71M
Short % of float—
Dividend yield2.49%
Beta (5Y)0.83
Valuation & profitability ratios
Trailing P/E20.62
Forward P/E17.00
PEG ratio1.77
Price / sales—
Price / book2.35
EV / revenue2.48
EV / EBITDA14.30
Gross margin39.02%
Operating margin16.41%
Profit margin9.55%
Return on equity12.15%
Return on assets4.48%
Debt / equity78.30
Current ratio1.16
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $23.38B | $22.36B | $21.68B | $21.71B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $2.14B | $1.94B | $1.51B | $2.04B |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $2.14B | $1.94B | $1.51B | $2.04B |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.53 | 0.70 | +33.1% |
| Mar 2026 | 0.51 | 0.53 | +4.8% |
| Dec 2025 | 0.44 | 0.49 | +11.1% |
| Sep 2025 | 0.69 | 0.68 | -0.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.68 | 4 | $6.85B | +8.3% |
| Next quarter | 0.50 | 1 | $5.80B | +7.4% |
| Current year | 2.34 | 19 | $23.60B | +1.0% |
| Next year | 2.36 | 19 | $25.00B | +5.9% |
Analyst targets & ownership
Mean target$45.10
High target$57.40
Low target$36.00
Implied upside12.18%
Analyst count20
ConsensusBUY
Strong buy / Buy4 / 9
Hold7
Sell / Strong sell0 / 0
Held by insiders67.02%
Held by institutions13.40%
Institutions holding467
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
747.27M
Total on file
Moving averages & technicals
SMA 10
39.46
+1.88% from price
SMA 20
38.68
+3.93% from price
SMA 50
36.27
+10.85% from price
SMA 100
35.83
+12.20% from price
SMA 200
39.02
+3.01% from price
EMA 12
39.26
+2.39% from price
EMA 26
38.16
+5.35% from price
EMA 50
37.14
+8.25% from price
RSI (14)
68.8
Neutral
MACD (12,26,9)
1.10
Hist 0.01
ATR (14)
0.67
1.66% of price
Realised vol 30D
29.6%
Annualised
Bollinger upper
41.26
20, 2σ
Bollinger lower
36.10
20, 2σ
50 / 200 cross
Death
36.27 vs 39.02
Trend bias
Above 200
+3.01%
Risk profile
Beta vs SPY
0.09
Less volatile than market
Correlation to SPY
0.05
Largely independent
Realised vol 30D
29.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-32.6%
Peak to trough
Max drawdown 5Y
-50.3%
Peak to trough
ATR 14
0.67
1.66% of price
Beta (reported)
0.83
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Ken de la Bastide column: Residents will be dealing with flooding for years
The Herald Bulletin, Anderson, Ind. · 5m ago
Germany's Merz to press cabinet for faster pro-growth reforms
Reuters · 10m ago
Teen killed at California high school football game; suspect arrested
USA TODAY · 17m ago
Real Madrid snatch late win at Espanyol on Mourinho's return
AFP · 21m ago
Social Security’s $184,500 Wage Cap Is Under Fire. Here’s Exactly Who Would Pay More
24/7 Wall St. · 22m ago
Maresca says Man City must fill Rodri void after Barca switch
AFP · 26m ago
ASEAN Records and ASIA Records Announce Major Expansion as Verified Record Certification Grows Across Asia
TMX Newsfile · 31m ago
Institutional Investors Are Buying Hyperliquid Strategies. Should You?
Motley Fool · 32m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.